Latest

Latest oncology News | Page 6

  • Latest oncology news stories and updates. What is happening today? All recent oncology news and developments. Live coverage and timeline of oncology. All you need to know about oncology.
Warrnambool is the next stop on Breast Cancer Network Australia’s tour of regional Australia
Enhertu showed clinically meaningful and durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial
Differences in animal biology can affect cancer drug development
Greenslopes Private Hospital offers new program to treat cancer at home
Radiotherapy optional for older breast cancer patients
AusBiotech develops first biotech ESG guidance
Study aims to cut pain and enhance chemo for ovarian cancer patients
Datopotamab deruxtecan showed promising responses as monotherapy and in combination with Imfinzi
Datopotamab deruxtecan showed encouraging and durable efficacy in patients with heavily pretreated HR-positive
Camizestrant significantly delayed disease progression in advanced ER-positive breast cancer
Capivasertib plus Faslodex reduced risk of disease progression or death by 40% versus Faslodex
Enhertu achieved statistically significant overall survival, reducing risk of death by 36% vs. trastuzumab emtansine
Noxopharm provides update on trial of its oncology drug candidate
AstraZeneca aims to redefine breast cancer care with new data across treatment spectrum at SABCS 2022
Allens advises IFM Investors on buyout of PRP Diagnostic Imaging
International Gynecologic Cancer Society expands gynecologic oncology fellowships for improved access to cervical cancer treatment
Telix announces positive topline results of late-stage imaging study
Keeping patients safe from Covid at WA hospitals
Helping Rockhampton access best breast cancer care
Novel technique reveals surprising way to suppress tumor cells
Naponda Hospital Auxiliary
Helping patients to find early answers
Imfinzi plus chemotherapy further improved overall survival benefit in advanced biliary tract cancer
Imfinzi and tremelimumab with chemotherapy demonstrated sustained survival benefit
Enhertu continues to demonstrate clinically meaningful tumour response
Tagrisso demonstrated 5.5-year median disease-free survival in adjuvant treatment of patients with EGFR-mutated lung cancer
Townsville Senior of Year recipients named
Prescient Therapeutics launches share purchase plan to raise $8 million
EpiAxis Therapeutics and Peptilogics announce new collaboration
Enhertu significantly delayed disease progression in DESTINY-Breast02 Phase III trial vs. physician’s choice of treatment
Ashurst advises FSI on investment in Sterling
Critical oncology trial data remains hidden
Startup program unearths new talent
Collaboration streamlines integration of rich data from medicines access programs to advance cancer treatments
New data shows higher survival rates for childhood cancers
Breast cancer support comes to Tasmania
Immutep reports positive overall response rate in lung cancer trial
Enhertu reduced risk of disease progression or death by 50% vs. chemotherapy
Calquence plus obinutuzumab demonstrated sustained survival benefit
Dr. Pavan Reddy named director of Dan L Duncan Comprehensive Cancer Center
New appointment to Imugene’s scientific advisory board
Ashurst advises Atomic Oncology on series seed capital raise
ARPANSA leads world first in film dosimetry
Digital health support systems help improve health for people with breast cancer
Breast cancer support comes to Ballarat as BCNA welcomes back face-to-face information forums
First quarter 2022 results
Enhertu granted Breakthrough Therapy Designation in US for patients with HER2-low metastatic breast cancer
Enhertu granted Priority Review in US for patients with previously treated HER2-mutant metastatic non-small cell lung cancer

© 2026 - The National Tribune Australia